Oxacyclohexadecane-2,13-dione
Common Name: |
Oxacyclohexadecane-2,13-dione |
IUPAC Name: |
oxacyclohexadecane-2,13-dione |
Molecular Formula: |
C12H22O3 |
SMILES: |
C1CCCCCC(=O)OCCCC(=O)CCCC1 |
Inchi: |
1S/C15H26O3/c16-14-10-7-5-3-1-2-4-6-8-12-15(17)18-13-9-11-14/h1-13H2 |
Inchi Key: |
QFRZEGADDLNLLM-UHFFFAOYSA-N |
Cas No: |
38223-29-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
214.30 |
Mass (g/mol) |
254.188 |
Molar Refractivity |
61.77 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
10 |
Rings |
1 |
TPSA |
54.37 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
422.00 to 423.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
3.794 |
iLOGP |
2.44 |
XLOGP3 |
3.00 |
WLOGP |
3.17 |
MLOGP |
2.16 |
ESOL Log S |
-2.40 |
ESOL Solubility (mg/ml) |
0.856 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.81 |
Ali Solubility (mg/ml) |
0.03 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.24 |
Silicos-IT Solubility (mg/ml) |
0.12 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.48 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.697 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.563 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |